Seeing Is Believing
Healthcare - Sector
KROS is currently covered by 8 analysts with an average price target of $33.33. This is a potential upside of $14.13 (73.59%) from yesterday's end of day stock price of $19.2.
Keros Therapeutics 's activity chart (see below) currently has 62 price targets and 66 ratings on display. The stock rating distribution of KROS is 68.75% BUY and 31.25% HOLD.
Analysts average stock forecasts to be materialized ratio is 39.48% with an average time for these price targets to be met of 54.92 days.
Highest price target for KROS is $27, Lowest price target is $15, average price target is $22.86.
Most recent stock forecast was given by ANDREAS ARGYRIDES from OPPENHEIMER on 12-Nov-2025. First documented stock forecast 04-May-2020.
Currently out of the existing stock ratings of KROS, 11 are a BUY (68.75%), 5 are a HOLD (31.25%).
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 31-Jul-2023
$27
$7.8 (40.63%)
$23
1 months 30 days ago
(12-Nov-2025)
0/8 (0%)
$9.53 (54.55%)
Hold
Since 17-Jan-2025
$16
$-3.2 (-16.67%)
$15
2 months 5 days ago
(06-Nov-2025)
3/4 (75%)
$-0.17 (-1.05%)
70
Buy
Since 08-Dec-2023
$26
$6.8 (35.42%)
$26
2 months 22 days ago
(20-Oct-2025)
1/4 (25%)
$10.81 (71.17%)
74
Buy
Since 26-Jul-2023
$26
$6.8 (35.42%)
$41
7 months 30 days ago
(12-May-2025)
1/6 (16.67%)
$12.26 (89.23%)
215
Buy
Since 04-May-2020
$25
$5.8 (30.21%)
$40
8 months 3 days ago
(08-May-2025)
1/14 (7.14%)
$10.98 (78.32%)
113
What is KROS (Keros Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on KROS (Keros Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on KROS (Keros Therapeutics )?
Which analyst is the currently most bullish on KROS (Keros Therapeutics )?
Which analyst is the currently most reserved on KROS (Keros Therapeutics )?